The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses ...
In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect ... Harris Administration and HHS,” HHS Secretary Xavier Becerra said in a statement Friday.
“This latest intended investment illustrates the Biden-Harris Administration’s robust response to emerging disease threats such as avian influenza,” said Health Secretary Xavier Becerr ...
The award will also support the expansion of clinical studies for up to five additional subtypes of pandemic influenza ... HHS Secretary Xavier Becerra said in a statement: “Avian flu variants ...
"This latest intended investment illustrates the Biden-Harris Administration's robust response to emerging disease threats such as avian influenza," said health secretary Xavier Becerra. Companies ...
The award will also support the expansion of clinical studies for up to five additional subtypes of pandemic influenza ... stay safe,” HHS Secretary Xavier Becerra said in a statement.